Literature DB >> 22654249

Percutaneous renal cryoablation complicated by hemorrhage.

Jeffrey Critchfield1, Joe Harb.   

Abstract

The authors describe a case in which a patient underwent percutaneous cryoablation of a suspected right renal cell carcinoma complicated by bleeding. Urgent angiography revealed a lower renal pole arteriovenous (AV) fistula, correlating with the recent treatment site. This AV fistula was successfully treated with coil and Gelfoam embolization. Three days later, the patient's hemoglobin dropped following dialysis. Computed tomography (CT) imaging revealed an increase in the size of the pararenal hematoma. There were multiple pseudoaneurysms as well as a small AV fistula on repeat angiography. The right main renal artery was coil embolized.

Entities:  

Keywords:  Renal; ablation; complications; cryoablation; hemorrhage; postprocedure

Year:  2011        PMID: 22654249      PMCID: PMC3193321          DOI: 10.1055/s-0031-1280651

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  15 in total

Review 1.  Clinical practice. Small renal mass.

Authors:  Inderbir S Gill; Monish Aron; Debra A Gervais; Michael A S Jewett
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

2.  Cryoablation vs. radiofrequency ablation for small renal masses.

Authors:  Ali Pirasteh; Laura Snyder; Nicholas Boncher; Matthew Passalacqua; David Rosenblum; J David Prologo
Journal:  Acad Radiol       Date:  2010-09-29       Impact factor: 3.173

3.  Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.

Authors:  Patrick C Malloy; Clement J Grassi; Sanjoy Kundu; Debra Ann Gervais; Donald L Miller; Robert B Osnis; Darren W Postoak; Dheeraj K Rajan; David Sacks; Marc S Schwartzberg; Darryl A Zuckerman; John F Cardella
Journal:  J Vasc Interv Radiol       Date:  2009-04-25       Impact factor: 3.464

4.  Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma.

Authors:  Ronald Rodriguez; Ziga Cizman; Kelvin Hong; Alexandra Koliatsos; Christos Georgiades
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-14       Impact factor: 2.740

5.  Prophylactic gelatin sponge tract injection to prevent bleeding after percutaneous renal cryoablation in a swine model.

Authors:  Sompol Permpongkosol; Theresa L Nicol; Herman S Bagga; Sahar Kohanim; Louis Kavoussi; Stephen B Solomon
Journal:  J Vasc Interv Radiol       Date:  2006-09       Impact factor: 3.464

Review 6.  Increased incidence of serendipitously discovered renal cell carcinoma.

Authors:  M Jayson; H Sanders
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

7.  Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review.

Authors:  D Brooke Johnson; Stephen B Solomon; Li-Ming Su; Edward D Matsumoto; Louis R Kavoussi; Stephen Y Nakada; Timothy D Moon; W Bruce Shingleton; Jeffrey A Cadeddu
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

8.  Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.

Authors:  Ronald J Zagoria; Ashley D Hawkins; Peter E Clark; M Craig Hall; Brian R Matlaga; Raymond B Dyer; Michael Y Chen
Journal:  AJR Am J Roentgenol       Date:  2004-07       Impact factor: 3.959

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience.

Authors:  M Pilar Laguna; Patricia Beemster; Vivenkanandar Kumar; Patricia Kumar; H Christoph Klingler; Stephen Wyler; Chris Anderson; Francis X Keeley; Alexander Bachmann; Jorge Rioja; Charalampos Mamoulakis; Michael Marberger; Jean J de la Rosette
Journal:  Eur Urol       Date:  2009-05-13       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.